{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-024392","form_type":"8-K","ticker":"DMAA","cik":"0002028614","company_name":"Drugs Made In America Acquisition Corp.","filed_at":"2026-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.037635+00:00","generated_at":"2026-05-15T19:04:30.772060+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"CEO Lynn Stockwell resigns after affiliate fund irregularities; Roger Bendelac appointed CEO","bullets":["Lynn Stockwell resigned as CEO, Executive Chair, and Board member of DMAA and affiliate, effective Feb 28, 2026.","Resignation followed board request after Sponsor withdrew ~$1.1M from affiliate's account, including ~$566K overpayment and $200K for unrelated expenses; Sponsor cannot repay.","Roger Bendelac appointed as new CEO; has 30+ years in investment banking/corporate advisory; compensation not yet determined.","Board removed Ms. Stockwell from all positions on Feb 28, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-024392","json":"https://secwatch.observer/filing/0001213900-26-024392.json","markdown":"https://secwatch.observer/filing/0001213900-26-024392.md","text":"https://secwatch.observer/filing/0001213900-26-024392.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2028614/000121390026024392/0001213900-26-024392-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2028614/000121390026024392/ea0280328-8k_drugs.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T19:04:30.772060+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}